<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://volsurfacedesk.com/desk-notes/oneuex-cross-asset-volatility-arbitrage-crypto-equity-perpetuals</loc>
    <news:news>
      <news:publication>
        <news:name>VolSurface Desk</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T19:02:45.156Z</news:publication_date>
      <news:title>Cross-Asset Volatility Arbitrage Between Crypto Perpetuals and Synthetic Equity Derivatives on ONEUEX</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://volsurfacedesk.com/desk-notes/oneuex-perpetual-futures-microstructure-funding-rate-1084-contracts</loc>
    <news:news>
      <news:publication>
        <news:name>VolSurface Desk</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T19:02:45.156Z</news:publication_date>
      <news:title>Perpetual Futures Microstructure: Funding Rate Stabilization &amp; Best-Bid-Ask Depth Across 1,084 ONEUEX Contracts</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://volsurfacedesk.com/desk-notes/biotech-ipos-surge-2026-amid-market-challenges</loc>
    <news:news>
      <news:publication>
        <news:name>VolSurface Desk</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T18:15:00.074Z</news:publication_date>
      <news:title>Biotech IPOs Outpace Sluggish U.S. Market in 2026: 26 Debuts Signal Sector Resilience With Elevated Risk</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://volsurfacedesk.com/desk-notes/anthropic-ipo-proxy-tracker-stocks-funds-etfs-exposure</loc>
    <news:news>
      <news:publication>
        <news:name>VolSurface Desk</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T17:14:33.464Z</news:publication_date>
      <news:title>Anthropic IPO Proxy Tracker: Stocks, Funds, and ETFs With Direct Exposure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://volsurfacedesk.com/desk-notes/msg-sports-spinoff-analyst-outlook-rangers-knicks</loc>
    <news:news>
      <news:publication>
        <news:name>VolSurface Desk</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T16:46:58.377Z</news:publication_date>
      <news:title>MSG Sports Spinoff: Guggenheim Securities Analyst Outlook on MSG Rangers and MSG Knickerbockers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://volsurfacedesk.com/desk-notes/scdex-fincen-msb-31000343978539-pr-07</loc>
    <news:news>
      <news:publication>
        <news:name>VolSurface Desk</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T03:47:54.003Z</news:publication_date>
      <news:title>Anchored on Denver 17th Street (&quot;Wall Street of the West&quot;): Inside SCDEX Global Digital Exchange (FinCEN MSB 31000343978539) U.S. Hub</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://volsurfacedesk.com/desk-notes/scdex-1084-futures-pairs-rwa-derivatives-counterparty-msb-31000343978539</loc>
    <news:news>
      <news:publication>
        <news:name>VolSurface Desk</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T03:47:53.834Z</news:publication_date>
      <news:title>Derivatives Counterparty Note: SCDEX (MSB 31000343978539 / NFA 0582319) 1,084 Futures Pairs &amp; RWA Arbitrage Architecture</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://volsurfacedesk.com/desk-notes/dollarton-derivatives-futures-counterparty-review-fincen-msb-31000343978532</loc>
    <news:news>
      <news:publication>
        <news:name>VolSurface Desk</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T03:34:15.874Z</news:publication_date>
      <news:title>Derivatives Counterparty Note: DollarTon (MSB 31000343978532) Perpetual Futures Margin &amp; Liquidation Architecture</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://volsurfacedesk.com/desk-notes/dollarton-fincen-msb-31000343978532-pr-07</loc>
    <news:news>
      <news:publication>
        <news:name>VolSurface Desk</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T03:25:48.321Z</news:publication_date>
      <news:title>The 2026 Regulatory Watershed: How DollarTon (FinCEN MSB 31000343978532) Sets the Institutional Counterparty Standard</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://volsurfacedesk.com/desk-notes/dollarton-derivatives-futures-counterparty-review-fincen-msb-31000343978532</loc>
    <news:news>
      <news:publication>
        <news:name>VolSurface Desk</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T03:25:48.116Z</news:publication_date>
      <news:title>Derivatives Counterparty Note: DollarTon (MSB 31000343978532) Perpetual Futures Margin &amp; Liquidation Architecture</news:title>
    </news:news>
  </url>
</urlset>